Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Delrow

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Oncotarget|June 10, 2017
ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5Yu Ding, Jacob A Herman, Chad M Toledo, et al.
Molecular Oncology|April 23, 2009
Use of high density antibody arrays to validate and discover cancer serum biomarkersChristian M Loch, Arturo B Ramirez, Yan Liu, et al.
AIDS Research and Human Retroviruses|July 3, 2013
Differential regulatory T cell activity in HIV type 1-exposed seronegative individualsLaura Pattacini, Pamela M Murnane, Erin M Kahle, et al.
Breast Cancer Research and Treatment|September 16, 2010
Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparationC C Ton, N Vartanian, X Chai, et al.
Molecular and Cellular Biology|April 5, 2012
Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancerJonathan E Grim, Sue E Knoblaugh, Katherine A Guthrie, et al.
Genome Medicine|March 1, 2018
NSAID use and somatic exomic mutations in Barrett's esophagusPatricia C Galipeau, Kenji M Oman, Thomas G Paulson, et al.
Leukemia Research|January 26, 2017
The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myelomaNicholas Burwick, Michael Y Zhang, Pilar de la Puente, et al.
Genome Medicine|March 15, 2019
Correction to: NSAID use and somatic exomic mutations in Barrett's esophagusPatricia C Galipeau, Kenji M Oman, Thomas G Paulson, et al.
Nature Communications|July 10, 2021
Multiplexed functional genomic analysis of 5' untranslated region mutations across the spectrum of prostate cancerYiting Lim, Sonali Arora, Samantha L Schuster, et al.
Immunity|August 14, 2016
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during TumorigenesisAndrea Schietinger, Mary Philip, Varintra E Krisnawan, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Oncotarget|June 10, 2017
ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5Yu Ding, Jacob A Herman, Chad M Toledo, et al.
Molecular Oncology|April 23, 2009
Use of high density antibody arrays to validate and discover cancer serum biomarkersChristian M Loch, Arturo B Ramirez, Yan Liu, et al.
AIDS Research and Human Retroviruses|July 3, 2013
Differential regulatory T cell activity in HIV type 1-exposed seronegative individualsLaura Pattacini, Pamela M Murnane, Erin M Kahle, et al.
Breast Cancer Research and Treatment|September 16, 2010
Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparationC C Ton, N Vartanian, X Chai, et al.
Molecular and Cellular Biology|April 5, 2012
Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancerJonathan E Grim, Sue E Knoblaugh, Katherine A Guthrie, et al.
Genome Medicine|March 1, 2018
NSAID use and somatic exomic mutations in Barrett's esophagusPatricia C Galipeau, Kenji M Oman, Thomas G Paulson, et al.
Leukemia Research|January 26, 2017
The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myelomaNicholas Burwick, Michael Y Zhang, Pilar de la Puente, et al.
Genome Medicine|March 15, 2019
Correction to: NSAID use and somatic exomic mutations in Barrett's esophagusPatricia C Galipeau, Kenji M Oman, Thomas G Paulson, et al.
Nature Communications|July 10, 2021
Multiplexed functional genomic analysis of 5' untranslated region mutations across the spectrum of prostate cancerYiting Lim, Sonali Arora, Samantha L Schuster, et al.
Immunity|August 14, 2016
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during TumorigenesisAndrea Schietinger, Mary Philip, Varintra E Krisnawan, et al.
Pageof 5